Compile Data Set for Download or QSAR
maximum 50k data
Found 46 Enz. Inhib. hit(s) with all data for entry = 2475
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367616(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367661(2-chloro-N-((1R,2R)-1-(4- cyclopropoxy-3-fluorophe...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367618(N-((1R,2R)-1-(8-fluoro-2,3- dihydrobenzo[b][1,4]di...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367617(N-((1R,2R)-1-(4-cyclopropoxy-3- fluorophenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367660(N-((1R,2R)-1-(4-cyclopropoxy-3- fluorophenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367659(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367651(2-chloro-N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphe...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367650(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367649(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367648(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367647(8-chloro-N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphe...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367645(N-((1R,2R)-3-(azetidin-1-yl)-1-(3- chloro-4-cyclop...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367644(N-((1R,2R)-1-(4-cyclopropoxyphenyl)- 1-hydroxy-3-(...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367643(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367642(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367641(N-((1R,2R)-3-(azetidin-1-yl)-1-(3- chloro-4-cyclop...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367640(N-((1R,2R)-1-(4-cyclopropoxyphenyl)- 1-hydroxy-3-(...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367637(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367635(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367632(N-((1R,2R)-1-(4-cyclopropoxy-3- fluorophenyl)-1-hy...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367629(7-(5-chlorothiophen-2-yl)-N-((1R,2R)- 1-(4-cyclopr...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367624(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxy-3-...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367623(7-(5-chlorothiophen-2-yl)-N-((1R,2R)- 1-(4-cyclopr...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367622(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxy-3-...)
Affinity DataIC50:  5.5nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367639(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367620(N-((1R,2R)-3-(azetidin-1-yl)-1-(3- chloro-4-cyclop...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367621(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxyphe...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367658(8-chloro-N-((1R,2R)-1-(4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367625(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367626(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxyphe...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367619(N-((1R,2R)-1-(4-cyclopropoxyphenyl)- 1-hydroxy-3-(...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367654(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxyphe...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367636(N-((1R,2R)-3-(azetidin-1-yl)-1-(3- chloro-4-cyclop...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367646(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxyphe...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367634(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367633(7-(5-chlorothiophen-2-yl)-N-((1R,2R)- 1-(4-cyclopr...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367653(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367652(N-((1R,2R)-1-(4-cyclopropoxy-3- fluorophenyl)-1-hy...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367628(7-chloro-N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphe...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367627(7-chloro-N-((1R,2R)-1-(4- cyclopropoxy-3-fluorophe...)
Affinity DataIC50:  55nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367631(N-((1R,2R)-3-(azetidin-1-yl)-1-(3- chloro-4-cyclop...)
Affinity DataIC50:  550nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367656(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  550nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367657(7-chloro-N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphe...)
Affinity DataIC50:  550nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367638(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  550nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367630(N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxy-3-...)
Affinity DataIC50:  550nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCeramide glucosyltransferase(Homo sapiens (Human))
Biomarin Pharmaceutical

US Patent
LigandPNGBDBM367655(N-((1R,2R)-1-(3-chloro-4- cyclopropoxyphenyl)-1-hy...)
Affinity DataIC50:  550nMAssay Description:This assay was modified based on the study by Larsen et al. (J. Lipid Res. 2011, 53, 282). Madin-Darby canine kidney (MDCK) cell lysate was prepared ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent